Latest news
How Investors Are Reacting To Ultragenyx Pharmaceutical (RARE) Q2 Revenue Gain And Narrower Net Loss - simplywall.stsimplywall.st · Mon, 10 Aug 2026 08:33:04 GMTMRNA, LNTH, BMY, CAPR, RARE Stocks In Focus — These FDA Decisions Could Shape August Trading - TradingViewTradingView · Mon, 03 Aug 2026 21:26:12 GMT